[1]叶维法.临床肝胆病学[M].第2版.天津:中国医药科技出版社, 2000∶95.
|
[2]Maggs JR, Chapman RW.An update on primary sclerosingcholangitis[J].Curr Opin Gastroenterol, 2008, 24 (3) ∶377-383.
|
[3]Berstad AE, Aabakken L, Smith HJ, et al.Diagnostic accuracy ofmagnetic resonance and endoscopic retrograde cholangiography in pri-mary sclerosing cholangitis[J].Clin Gastroenterol Hepatol, 2006, 4 (4) ∶514-520.
|
[4]邱德凯, 马雄.自身免疫性肝病基础与临床[M].上海:科学技术出版社, 2006∶268.
|
[5] 吕红, 钱家鸣.自身免疫性胰腺炎不同诊断标准的探讨[J].胃肠病学, 2009, 14 (1) ∶4-7.
|
[6]Tischendorf JJ, Geier A, Trautwein C.Current diagnosis and manage-ment of primary sclerosing cholangitis[J].Liver Transpl, 2008, 14 (6) ∶735-746.
|
[1] | Lili ZHANG, Aiwen GENG, Chuanwang QI, Jianchun XIAN. Association between immunoglobulin G4-related diseases and autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2021, 37(12): 2972-2975. doi: 10.3969/j.issn.1001-5256.2021.12.050 |
[2] | Tu RongFang, Yang Xue, Tang YingMei. Research advances in primary biliary cholangitis with extrahepatic autoimmune diseases[J]. Journal of Clinical Hepatology, 2020, 36(6): 1398-1401. doi: 10.3969/j.issn.1001-5256.2020.06.046 |
[3] | Meng Miao, Hu Zhen, Gong Lei, Lu ZhongHua, Peng XiaoBin, Tang XueJun, Wang XiaoYun. Autoantibody-negative autoimmune hepatitis overlapping with primary biliary cholangitis and primary sclerosing cholangitis: A case report[J]. Journal of Clinical Hepatology, 2019, 35(8): 1806-1808. doi: 10.3969/j.issn.1001-5256.2019.08.032 |
[4] | Ma Juan, Liu YuLan. Corticosteroid therapy for autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2018, 34(8): 1599-1603. doi: 10.3969/j.issn.1001-5256.2018.08.002 |
[5] | Jiang JiChang, Zhao LiJin, Tu Kui, Sun XianLong. IgG4-related sclerosing cholangitis: A case report[J]. Journal of Clinical Hepatology, 2018, 34(12): 2659-2661. doi: 10.3969/j.issn.1001-5256.2018.12.031 |
[6] | Du HengRui, Wang ZhenJiang, Ren YanXian, Ma ZhiJian, Wang KeShen, Zhan Hao, Yu ZeYuan, Jiao ZuoYi. A case of missed diagnosis of IgG4-related sclerosing cholangitis[J]. Journal of Clinical Hepatology, 2018, 34(10): 2206-2207. doi: 10.3969/j.issn.1001-5256.2018.10.031 |
[7] | Li YuHan, Xiang XiaoXing. Research advances in immunoglobulin G4-related sclerosing cholangitis[J]. Journal of Clinical Hepatology, 2017, 33(11): 2239-2242. doi: 10.3969/j.issn.1001-5256.2017.11.042 |
[8] | Zhu ChunWu, Yuan JiLi, Liu ChengHai. Primary sclerosing cholangitis with dermatomyositis:a case report[J]. Journal of Clinical Hepatology, 2017, 33(3): 528-531. doi: 10.3969/j.issn.1001-5256.2017.03.029 |
[9] | Wang TingTing, Lu ChangLi, Fan XiaoLi, Yang Li. Clinical and pathological features of autoimmune hepatitis-primary biliary cholangitis overlap syndrome versus autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2017, 33(11): 2179-2185. doi: 10.3969/j.issn.1001-5256.2017.11.026 |
[10] | Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and management of primary sclerosing cholangitis(2015)[J]. Journal of Clinical Hepatology, 2016, 32(1): 23-31. doi: 10.3969/j.issn.1001-5256.2016.01.003 |
[11] | Ye Dan, Li GuoHua. Current status of diagnosis and treatment of IgG4-related sclerosing cholangitis[J]. Journal of Clinical Hepatology, 2016, 32(10): 2021-2025. doi: 10.3969/j.issn.1001-5256.2016.10.047 |
[12] | Yin Tao, Wu HeShui. Progress in diagnosis and treatment of autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2015, 31(5): 665-667. doi: 10.3969/j.issn.1001-5256.2015.05.006 |
[13] | Xu BeiLi, Tu ChuanTao. A case report of IgG4-related sclerosing cholangitis[J]. Journal of Clinical Hepatology, 2015, 31(11): 1910-1911. doi: 10.3969/j.issn.1001-5256.2015.11.038 |
[14] | Han Ying, Zhu JiangYi. Autoimmune sclerosing cholangitis: new concept and new evidence[J]. Journal of Clinical Hepatology, 2015, 31(2): 171-173. doi: 10.3969/j.issn.1001-5256.2015.02.006 |
[15] | Ren Song, Ye ZhaoXiang, Zhu LiMin. Research progress in type I autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2014, 30(2): 189-193. doi: 10.3969/j.issn.1001-5256.2014.02.023 |
[16] | Li Ji, Qian JiaMing. Advances in treatment of autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2013, 29(7): 496-498. doi: 1001-5256 (2013) 07-0496-03 |
[17] | Cheng Peng, Yao JianNing, Wang ChunFeng. Clinical efficacy of cyclophosphamide in treatment of primary sclerosing cholangitis[J]. Journal of Clinical Hepatology, 2013, 29(12): 929-931. doi: 10.3969/j.issn.1001-5256.2013.12.014 |
[18] | Zhou SuMin, Gao PuJun. Advancement in the treatment of two subtypes of autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2011, 27(11): 1219-1221. |
[19] | Zhou SuMin, Gao PuJun, Gao RunPing. A case report of autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2011, 27(4): 424+43. |
[20] | Hu YuLin, Zhang Rong. Clinical features, diagnosis and treatment of autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2010, 26(5): 487-489. |